Stock Screener App

Frei -

Installieren

39.89

1.29% -0.52

after-market

Handel nachbörslich: 39.95 0.06 +0.15%

Spyre Therapeutics Inc (SYRE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Spyre Therapeutics Inc-Aktie (SYRE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	0.50% 57.17	56.89	41.94	53.57	55.39
Operating Income/Loss	0.50% -57.17	-56.89	-41.94	-53.57	-55.39
Nonoperating Income/Loss	111.72% -5.358	45.70	5.218	8.779	-13.62
Income/Loss From Continuing Operations Before Tax	459.15% -62.53	-11.18	-36.72	-44.79	-69.01
Income Tax Expense/Benefit	-	-	-	-0.015	0.018
Income/Loss From Continuing Operations After Tax	459.15% -62.53	-11.18	-36.72	-44.77	-69.03
Net Income/Loss	459.15% -62.53	-11.18	-36.72	-44.77	-69.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters